The role of sex in explaining the heterogeneity of type 1 diabetes
Authors: Ferrat, Lauric A; Templeman, Erin L; Sims, Emily K
Source journal: Diabetologia (2026-11-18)
DOI: 10.1007/s00125-026-06927-8
Abstract
Type 1 diabetes is increasingly recognised as a heterogeneous disease with substantial variability in risk, progression, metabolic control and complications. Biological sex is a critical but understudied contributor to this heterogeneity. This review synthesises epidemiological, mechanistic and clinical evidence that sex influences multiple dimensions of type 1 diabetes, including disease epidemiology, the underlying pathophysiology, clinical presentation, complications and treatment responses. These effects are highly dynamic and shaped by interactions among age, hormonal transitions, genetic susceptibility and environmental exposures. Recognition of sex-specific heterogeneity has important implications for screening, risk prediction, monitoring and therapeutic development. We propose that future type 1 diabetes research moves beyond treating sex solely as a covariate and instead incorporates appropriately powered sex-stratified analyses and hormonal context to determine when sex meaningfully modifies disease risk, progression or treatment response.
Related topics
Related open access articles
- IMMUNE RELATED DISEASES AND THEIR RELATIONSHIP WITH THE GENETIC VARIABILITY WITHIN THE ADENOSINE DEAMINASE GENE
- ENTEROPARASITES, RESPIRATORY ALLERGY AND OTHER SIGNS AND SYMPTOMS IN CHILDS AND YOUTH POPULATION OF RECÔNCAVO OF BAHIA – BRAZIL
- Proctocolitis in a child treated with oral immunotherapy for cow’s milk allergy
- Non-ionic Contrast Allergy Manifesting as Stevens Johnson Syndrome and Erythema Multiforme
- Can dietary intervention be an auxiliary therapy for Rheumatoid Arthritis?
Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.